Findings from Shiah et al. support our hypothesis regarding NFκB-inhibition in pancreatic ductal adenocarcinoma (PDAC) cancer cell line, Panc-1, using the synthetic tylophorine analogue DCB-3503. The gene discussed is NFKB1; the disease is cancer.